BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1371920)

  • 1. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
    Yamamoto K; Kawanishi S
    Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
    Yamamoto K; Sugiyama H; Kawanishi S
    Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
    Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
    Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
    McHugh MM; Sigmund RD; Beerman TA
    Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
    Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
    Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
    Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
    McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
    Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
    Ginsburg H; Nissani E; Krugliak M; Williamson DH
    Mol Biochem Parasitol; 1993 Mar; 58(1):7-15. PubMed ID: 7681547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The minor-groove binding DNA-ligands netropsin, distamycin A and berenil cause polyploidisation via impairment of the G2 phase of the cell cycle.
    Poot M; Kausch K; Köhler J; Haaf T; Hoehn H
    Cell Struct Funct; 1990 Jun; 15(3):151-7. PubMed ID: 1697788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence preferences of several AT-selective minor groove binding ligands.
    Abu-Daya A; Brown PM; Fox KR
    Nucleic Acids Res; 1995 Sep; 23(17):3385-92. PubMed ID: 7567447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distamycin A, a minor groove binder, changes enediyne-induced DNA cleavage sites and enhances apoptosis.
    Hiraku Y; Oikawa S; Kawanishi S
    Nucleic Acids Res Suppl; 2002; (2):95-6. PubMed ID: 12903122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA sequence dependent binding modes of 4',6-diamidino-2-phenylindole (DAPI).
    Wilson WD; Tanious FA; Barton HJ; Jones RL; Fox K; Wydra RL; Strekowski L
    Biochemistry; 1990 Sep; 29(36):8452-61. PubMed ID: 2252904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds.
    Kawanishi S; Hiraku Y
    Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):415-9. PubMed ID: 15379695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor groove binding ligands alter the rotational positioning of DNA fragments on nucleosome core particles.
    Brown PM; Fox KR
    J Mol Biol; 1996 Oct; 262(5):671-85. PubMed ID: 8876646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photofootprinting of drug-binding sites on DNA using diazo- and azido-9-aminoacridine derivatives.
    Jeppesen C; Nielsen PE
    Eur J Biochem; 1989 Jun; 182(2):437-44. PubMed ID: 2472274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
    Bell A; Kittler L; Löber G; Zimmer C
    Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distamycin-induced inhibition of formation of a nucleoprotein complex between the terminase small subunit G1P and the non-encapsidated end (pacL site) of Bacillus subtilis bacteriophage SPP1.
    Chai S; Alsonso JC
    Nucleic Acids Res; 1996 Jan; 24(2):282-8. PubMed ID: 8628651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
    Fesen M; Pommier Y
    J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition of B-DNA by Hoechst 33258.
    Harshman KD; Dervan PB
    Nucleic Acids Res; 1985 Jul; 13(13):4825-35. PubMed ID: 2410856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.